RESEARCH TRIANGLE PARK, North Carolna--RIEMSER, a leader in oral surgery technology, has announced the launch of AlloSorb,
AlloSorb is a cost-competitive allograft that provides a natural structure and framework to build healthy bone in the regeneration process. AlloSorb is a STERILE-R allograft certified by the American Association of Tissue Banks.
AlloSorb uses a sterilization and processing method, Allowash, a patented technology that minimizes the risk of disease transmission by facilitating the removal of cellular elements from musculoskeletal tissue without degrading the tissues ' structural integrity.
AlloSorb is low-dose irradiated. To help achieve patient safety, the AlloSorb screening process for donors meets or exceeds FDA regulations and AATB standards.
AlloSorb is available in three types of particulate--mineralized cancellous, demineralized cortical, and mineralized cortical--in 0.5 cc, 1.0 cc, and 2.0 cc vials. It will soon be available in block form.
"Our customers include oral surgeons, periodontists, and other implantologists who want RIEMSER to serve as a one-stop supplier for all their bone grafting needs, which is why we are pleased to add this safe, cost-competitive allograft product to our growing line," said Vince Ellero, director, national sales.
For more information, go to RIEMSER.
To read more about RIEMSER, go to RIEMSER.
To comment on this product, go to PennWell Dental Community site.